Current Problems in the Evaluation and Approval of New Antiarrhythmic Agents
Reference7 articles.
1. Winkle RA. 1979. Measuring antiarrhythmic drug efficacy by suppression of asymptomatic ventricular arrhythmias. Ann Int Med 91: 480–482.
2. Califf RM, McKinnis RA, Burks J, Lee KL, Harrell FE, Behar VS, Pryor DB, Wagner GS, Rosati RA. 1982. Prognostic implications of ventricular arrhythmias during 24 hour ambulatory monitoring in patients undergoing cardiac catheterization for coronary artery disease. Am J Cardiol 50: 23–31.
3. Velebit V, Podrid P, Lown B, Cohen BH, Graboys TB. 1982. Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs. Circulation 65: 886–894.
4. Ruskin JN, DiMarco JP, Garan H. 1980. Out-of-hospital cardiac arrest. Electrophysiologic observations and selection of long-term antiarrhythmic therapy. New Engl J Med 303: 607–613.
5. Naccarelli GV, Prystowky EN, Jackman WM, Heger JJ, Rahilly GT, Zipes DP. 1982. Role of electrophysiologic testing in managing patients who have ventricular tachycardia unrelated to coronary artery disease. Am J Cardiol 50: 165–171.